Pure Global

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults. - Trial NCT05750381

Access comprehensive clinical trial information for NCT05750381 through Pure Global AI's free database. This phase not specified trial is sponsored by BLIS Technologies Limited and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05750381
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05750381
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

Study Focus

Microbial Colonization

Micrococcus luteus Blis Q24 balm

Interventional

other

Sponsor & Location

BLIS Technologies Limited

Dunedin, New Zealand

Timeline & Enrollment

N/A

Jan 24, 2023

Apr 12, 2023

20 participants

Primary Outcome

Change in microbial composition on skin following application of Micrococcus luteus Q24 in balm from Day 0 (baseline) to 11 days,Change in microbial composition on skin following application of placebo balm from Day 0 (baseline) to 11 days,Change in microbial composition on skin post 10 days application of Micrococcus luteus Q24 in balm from Day 11 (baseline) to 18 days.,Change in microbial composition on skin post 10 day application application of placebo balm from Day 11 (baseline) to 18 days,Change in skin quality parameters following topical application Micrococcus luteus Q24 from Day 0 (baseline) to 11 days,Change in skin quality parameters following topical application of placebo balm from Day 0 (baseline) to 11 days,Change in skin quality parameters post 10 days application of Micrococcus luteus Q24 in balm from Day 11 (baseline) to 18 days.,Change in skin quality parameters post 10 days application of placebo balm from Day 11 (baseline) to 18 days.

Summary

The purpose of this study is to evaluate the skin quality improvement and colonization
 efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the
 elbow and back of forearm in a topical balm format in healthy adults.

ICD-10 Classifications

Bacterial infection of unspecified site
Other bacterial infections of unspecified site
Bacterial, viral and other infectious agents
Cholera
Other specified bacterial intestinal infections

Data Source

ClinicalTrials.gov

NCT05750381

Non-Device Trial